{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:17:32Z","timestamp":1793272652667,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.thromres.2024.109101","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T23:06:05Z","timestamp":1721516765000},"page":"109101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Anticoagulants for the treatment of isolated lower limb superficial vein thrombosis a Bayesian network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"241","author":[{"given":"Alkis","family":"Bontinis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Pouliopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vangelis","family":"Bontinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Liakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argirios","family":"Giannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Chatzimpalasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiriakos","family":"Ktenidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.thromres.2024.109101_bb0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejvs.2004.09.021","article-title":"Clinical significance of superficial vein thrombosis","volume":"29","author":"Leon","year":"2005","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"5","key":"10.1016\/j.thromres.2024.109101_bb0010","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/jth.13279","article-title":"Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis","volume":"14","author":"Di Minno","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2024.109101_bb0015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7326\/0003-4819-152-4-201002160-00006","article-title":"Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study","volume":"152","author":"Decousus","year":"2010","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.thromres.2024.109101_bb0020","article-title":"A systematic review and meta-analysis for the association between duration of anticoagulation therapy and the risk of venous thromboembolism in patients with lower limb superficial venous thrombosis","volume":"12","author":"Lobastov","year":"2024","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"key":"10.1016\/j.thromres.2024.109101_bb0025","doi-asserted-by":"crossref","unstructured":"S.K. Kakkos, M. Gohel, N. Baekgaard, R. Bauersachs, S. Bellmunt-Montoya, S.A. Black, A.J. Ten Cate-Hoek, I. Elalamy, F.K. Enzmann, G. Geroulakos, A. Gotts\u00e4ter, B.J. Hunt, A. Mansilha, A.N. Nicolaides, P.M. Sandset, G. Stansby, C. Esvs Guidelines, G.J. de Borst, F. Bastos Gon\u00e7alves, N. Chakf\u00e9, R. Hinchliffe, P. Kolh, I. Koncar, J.S. Lindholt, R. Tulamo, C.P. Twine, F. Vermassen, A. Wanhainen, R. Document, M.G. De Maeseneer, A.J. Comerota, P. Gloviczki, M. Kruip, M. Monreal, P. Prandoni, M. Vega de Ceniga, Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 clinical practice Guidelines on the Management of Venous Thrombosis, Eur. J. Vasc. Endovasc. Surg. 61(1) (2021) 9\u201382.","DOI":"10.1016\/j.ejvs.2020.09.023"},{"issue":"13","key":"10.1016\/j.thromres.2024.109101_bb0030","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJMoa0912072","article-title":"Fondaparinux for the treatment of superficial-vein thrombosis in the legs","volume":"363","author":"Decousus","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.thromres.2024.109101_bb0035","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2352-3026(17)30014-5","article-title":"Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial","volume":"4","author":"Beyer-Westendorf","year":"2017","journal-title":"Lancet Haematol"},{"issue":"3","key":"10.1016\/j.thromres.2024.109101_bb0040","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jrsm.1195","article-title":"GetReal in network meta-analysis: a review of the methodology","volume":"7","author":"Efthimiou","year":"2016","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.thromres.2024.109101_bb0045","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.thromres.2024.109101_bb0050","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network Meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2024.109101_bb0055","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.thromres.2024.109101_bb0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12874-019-0829-2","article-title":"BUGSnet: an R package to facilitate the conduct and reporting of Bayesian network Meta-analyses","volume":"19","author":"B\u00e9liveau","year":"2019","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.thromres.2024.109101_bb0065","article-title":"Network meta-analysis: application and practice using R software","volume":"41","author":"Shim","year":"2019","journal-title":"Epidemiol Health"},{"issue":"3","key":"10.1016\/j.thromres.2024.109101_bb0070","first-page":"160","article-title":"Therapeutic management of superficial venous thrombosis with calcium nadroparin. Dosage testing and comparison with a non-steroidal anti-inflammatory agent","volume":"43","author":"Titon","year":"1994","journal-title":"Ann Cardiol Angeiol (Paris)"},{"issue":"5","key":"10.1016\/j.thromres.2024.109101_bb0075","first-page":"523","article-title":"High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg","volume":"87","author":"Marchiori","year":"2002","journal-title":"A prospective, controlled, randomized study, Haematologica"},{"issue":"6","key":"10.1016\/j.thromres.2024.109101_bb0080","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1538-7836.2012.04727.x","article-title":"A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (superficial ThromboEmbolism and Fluxum)","volume":"10","author":"Cosmi","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2024.109101_bb0085","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1055\/s-0040-1718891","article-title":"Rivaroxaban compared to placebo for the treatment of leg superficial vein thrombosis: a randomized trial","volume":"46","author":"Kearon","year":"2020","journal-title":"Semin. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.thromres.2024.109101_bb0090","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/0003319714533183","article-title":"Time course and the recanalization rate of superficial vein thrombosis treated with low-molecular-weight heparin","volume":"66","author":"Spirkoska","year":"2015","journal-title":"Angiology"},{"issue":"6","key":"10.1016\/j.thromres.2024.109101_bb0095","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1538-7836.2005.01391.x","article-title":"High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial","volume":"3","author":"Prandoni","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2024.109101_bb0100","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1538-7836.2012.04669.x","article-title":"A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis","volume":"10","author":"Rathbun","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"14","key":"10.1016\/j.thromres.2024.109101_bb0105","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/archinte.163.14.1657","article-title":"A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis","volume":"163","year":"2003","journal-title":"Arch. Intern. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2024.109101_bb0110","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1111\/jth.12925","article-title":"Spontaneous acute superficial vein thrombosis of the legs: do we really need to treat?","volume":"13","author":"D\u00e9cousus","year":"2015","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2024.109101_bb0115","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.beha.2012.07.005","article-title":"Epidemiology, diagnosis, treatment and management of superficial-vein thrombosis of the legs","volume":"25","author":"Decousus","year":"2012","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.thromres.2024.109101_bb0120","unstructured":"A. Czysz, S.L. Higbee, Superficial thrombophlebitis, StatPearls, StatPearls Publishing."},{"key":"10.1016\/j.thromres.2024.109101_bb0130","doi-asserted-by":"crossref","unstructured":"C.P. Twine, S.K. Kakkos, V. Aboyans, I. Baumgartner, C.A. Behrendt, S. Bellmunt-Montoya, B. Jilma, J. Nordanstig, A. Saratzis, J.A. Reekers, P. Zlatanovic, G.A. Antoniou, G.J. de Borst, F. Bastos Gon\u00e7alves, N. Chakf\u00e9, R. Coscas, N.V. Dias, R.J. Hinchliffe, P. Kolh, J.S. Lindholt, B.M.E. Mees, T.A. Resch, S. Trimarchi, R. Tulamo, F.E.G. Vermassen, A. Wanhainen, I. Koncar, R. Fitridge, M. Matsagkas, M. Valgimigli, Editor's Choice - European Society for Vascular Surgery (ESVS) 2023 clinical practice Guidelines on antithrombotic therapy for vascular diseases, Eur. J. Vasc. Endovasc. Surg. 65(5) (2023) 627\u2013689.","DOI":"10.1016\/j.ejvs.2023.03.042"},{"issue":"3","key":"10.1016\/j.thromres.2024.109101_bb0135","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-0039-1677793","article-title":"Treatment of superficial vein thrombosis: a systematic review and Meta-analysis","volume":"119","author":"Duffett","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2024.109101_bb0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood-2014-06-577783","article-title":"Risk of venous and arterial thrombotic events in patients diagnosed with superficial vein thrombosis: a nationwide cohort study","volume":"125","author":"Cannegieter","year":"2015","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.thromres.2024.109101_bb0145","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012184","article-title":"Fondaparinux sodium compared with low-molecular-weight heparins for perioperative surgical Thromboprophylaxis: a systematic review and Meta-analysis","volume":"8","author":"Kumar","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.thromres.2024.109101_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(03)00030-6","article-title":"Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux)","volume":"109","author":"Samama","year":"2003","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2024.109101_bb0155","doi-asserted-by":"crossref","DOI":"10.1177\/10742484221145010","article-title":"Fondaparinux sodium: recent advances in the management of thrombosis","volume":"28","author":"Bauersachs","year":"2023","journal-title":"J. Cardiovasc. Pharmacol. Ther."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824002330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824002330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T22:17:59Z","timestamp":1724537879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824002330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":30,"alternative-id":["S0049384824002330"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109101","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulants for the treatment of isolated lower limb superficial vein thrombosis a Bayesian network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109101"}}